✦ LIBER ✦

A radiotherapeutic experience for non-hodgkin's lymphoma: the prognostic importance of histological grade and the role of combined chemotherapy

✍ Scribed by Kazushige Tsutsui; Yuta Shibamoto; Hirohiko Yamabe; Mitsuyuki Abe

Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 121 KB
Volume: 19
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(90)90867-j

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Radiotherapy for localized low grade non

Radiotherapy for localized low grade non-hodgkin's lymphoma: the role of combined chemotherapy and the prognostic factor

✍ Kazushige Tsutsui; Yuta Shibamoto; Mitsuyuki Abe 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 207 KB

Salvage chemotherapy for non Hodgkin's l

Salvage chemotherapy for non Hodgkin's lymphoma of unfavourable histology with a combination of ccnu and vinblastine

✍ Dr. G. Palmieri; R. Lauria; F. Caponigro; C. Pagliarulo; V. Montesarchio; F. Nuz 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB

Twenty patients with relapsed or refractory, intermediate or high grade non Hodgkin's lymphoma were treated with a combination of CCNU and vinblastine. Complete responses occurred in four patients (20 per cent), partial responses in eight (40 per cent), for an overall response rate of 60 per cent. T

Primary non-hodgkin's lymphoma of the na

Primary non-hodgkin's lymphoma of the nasal cavity : Prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy

✍ Ye-Xiong Li; Philippe A. Coucke; Jian-Ying Li; Da-Zhong Gu; Xin-Fan Liu; Li-Qian 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

## BACKGROUND. This study was conducted to determine whether the paranasal extension of a primary non-Hodgkin's lymphoma (NHL) of the nasal cavity has any deleterious effect on patient outcome. ## METHODS. One hundred and seventy-five patients with previously untreated nasal NHL were reviewed.

The treatment of stage III – IV non-Hodg

The treatment of stage III – IV non-Hodgkin'S lymphoma of “favorable” histologic type. A randomized comparison of whole body irradiation, combination chemotherapy, and single agent chemotherapy

✍ Richard T. Hoppe; Saul A. Rosenberg; Henry S. Kaplan 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Alternating chemotherapy regimen (P-VABE

Alternating chemotherapy regimen (P-VABEC) for intermediate and high-grade non-Hodgkin's lymphoma of the middle aged and elderly

✍ Dr. F. Caracciolo; M. Petrini; E. Capochiani; F. Papineschi; G. Carulli; B. Gras 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 463 KB 👁 1 views

An intensive third generation regimen (P-VABEC) including adriamycin, etoposide, cyclophosphamide. vincristine, bleomycin and prednisolone was administered to 43 unselected elderly patients with intermediate or high-grade non-Hodgkin's lymphomas (NHL). The median age was 67, 40 per cent were Ann Arb

CAVBP/DEP alternating chemotherapy for t

CAVBP/DEP alternating chemotherapy for the treatment of intermediate and high grade non Hodgkin's lymphoma: Final results of a pilot study

✍ Giovannella Palmieri; Dr. Francesco Caponigro; Rosario Vincenzo Iaffaioli; Alma 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

Between May 1984 and September 1986, 40 patients with intermediate or high grade non Hodgkin's lymphoma were treated with a novel protocol, which alternated a conventional regimen consisting of cyclophosphamide, doxorubicin, vincristine, bleomycin, and prednisone (CAVBP) with a second chemotherapy r